CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in ABEO — Abeona Therapeutics Inc.

CIK 884546 SAN FRANCISCO, CA

Position in ABEO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$569,448

-$130,950 QoQ

Shares Held

127,109

-4.4% QoQ

Ownership

0.223%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,185,699,337 across 288 Biotechnology names. ABEO ranks #221 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,920,871	$857,745,736
2	REGN	Regeneron Pharmaceuticals, Inc.	804,508	$621,595,061
3	MRNA	Moderna, Inc.	4,734,356	$240,505,284
4	ALNY	Alnylam Pharmaceuticals, Inc.	673,356	$222,793,299
5	INSM	INSMED Inc	1,069,390	$174,866,652
6	RVMD	Revolution Medicines, Inc.	1,735,476	$168,775,041
7	INCY	Incyte Corp	1,729,102	$162,743,080
8	BBIO	BridgeBio Pharma, Inc.	1,976,094	$146,744,740

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$569,448	127,109	-4.4%	Shares	Sole	2026-05-15
2025-12-31	$700,398	132,903	-0.5%	Shares	Sole	2026-02-13
2025-09-30	$705,196	133,560	-0.6%	Shares	Sole	2025-11-10
2025-06-30	$763,119	134,352	+449.3%	Shares	Sole	2025-08-12
2025-03-31	$116,415	24,457	+2.5%	Shares	Sole	2025-09-15
2024-12-31	$132,844	23,850	0.0%	Shares	Sole	2025-02-06
2024-09-30	$150,732	23,850	+32.5%	Shares	Sole	2024-11-12
2023-03-31	$50,760	18,000	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.